In his remarks, Dr Habeeb Badmus, President of ARD, University of Ilorin Teaching Hospital (UITH) chapter, said discovery of the
vaccine was a huge breakthrough and good news to Nigeria and Africa where the disease is endemic.
Badmus described malaria as one of the diseases that would continue to affect blacks in the sub-Saharan Africa due to the burden in deaths and mortality of children and pregnant women.
“The breakthrough will bring a lot of relief to the healthcare sector and will also go a long way in the treatment of malaria.
“Also, the economic impact of the burden of malaria, which generally affects the country, will be reduced,” he said.
Badmus appealed to the three tiers of government to make the vaccines available and affordable for the vulnerable.
He also called on researchers to strive and find vaccines for other diseases and conditions such as tuberculosis, HIV/AIDS and
malnutrition, among others.
Also, Dr Misbau Lawal, member of the Pharmaceutical Society of Nigeria (PSN), explained that the research for the malaria
vaccine had been on for more than 40 years.
Lawal, however, alleged that some pharmaceutical companies had always suppressed evolution of the vaccine.
According to him, this was counterproductive; adding that once there is vaccine, there would be no need for their drugs again.
“It has always been easy to manufacture. In Nigeria, there was attempt to invent the vaccines at he Ahmadu Bello University, Zaria,” he said.
“This vaccine produces anti-bodies against malaria parasite in the body, and highly antigenic against the parasite.
“For vaccine to be effective against malaria, it must be a polevarent vaccine, and must be prepared using four strains of the malaria
“These include parasitic protozoans causing malaria; Plasmodium Falciparum, Plasmodium Vivax, Plasmodium Ovate, and Plasmodium malaria.
Lawal said that with this breakthrough, malaria would be put under control and be gradually eradicated.(NAN)